Digbi Health is a pioneering health tech startup founded in 2018, based in the United States. The company’s cutting-edge slogan, "Gut Biome & Genetics based Precision Care Platform for Digestive and Obesity-associated mental and physical illnesses," reflects its focus on leveraging advanced technology to address complex health issues. The venture recently secured a Non-Equity Assistance investment on 08 December 2023, with PharmStars as the investing entity.
Digbi Health’s innovative approach involves utilizing AI to analyze clinical, genetic, gut microbiome, food, and behavioral data to identify root causes of illnesses. The company offers personalized care that encompasses remote monitoring, food-as-medicine, reducing pharmaceutical dependencies, and behavioral coaching to address diverse aspects of an individual’s well-being. This customer-centric model has earned Digbi Health praise for recognizing each person's unique physiology, lifestyle, and dietary habits.
Specializing in the Health Care sector, Digbi Health has positioned itself at the forefront of revolutionizing healthcare by incorporating advanced technologies and personalized approaches to tackle complex health challenges. The recent backing by PharmStars underscores the industry’s recognition of Digbi Health’s potential to make a significant impact on the health tech landscape.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | 08 Dec 2023 | |
Convertible Note | $3.00M | 1 | 01 Apr 2023 | |
Grant | $100.00K | 1 | 20 Jun 2022 | |
Series A | $5.40M | 4 | 20 Dec 2020 | |
Non Equity Assistance | Unknown | 1 | 17 Dec 2020 |
No recent news or press coverage available for Digbi Health.